Development of Large-Scale Routes to Potent GPR119 Receptor Agonists was written by Matsuoka, Richard T.;Boros, Eric E.;Brown, Andrew D.;Bullock, Kae M.;Canoy, Will L.;Carpenter, Andrew J.;Cobb, Jeremy D.;Condon, Shannon E.;Deschamps, Nicole M.;Elitzin, Vassil I.;Erickson, Greg;Fang, Jing M.;Igo, David H.;Joshi, Biren K.;Kaldor, Istvan W.;Mitchell, Mark B.;Peckham, Gregory E.;Reynolds, Daniel W.;Salmon, Matthew C.;Sharp, Matthew J.;Tabet, Elie A.;Toczko, Jennifer F.;Wu, Lianming Michael;Zhou, Xiao-ming M.. And the article was included in Organic Process Research & Development in 2016.Recommanded Product: 2-Bromo-5-chloropyrazine This article mentions the following:
Practical and scalable syntheses were developed that were used to prepare multi kilogram batches of GSK1292263A (1) and GSK2041706A (15), two potent G protein-coupled receptor 119 (GPR119) agonists. Both syntheses employed relatively cheap and readily available starting materials, and both took advantage of an SNAr synthetic strategy. In the experiment, the researchers used many compounds, for example, 2-Bromo-5-chloropyrazine (cas: 912773-21-8Recommanded Product: 2-Bromo-5-chloropyrazine).
2-Bromo-5-chloropyrazine (cas: 912773-21-8) belongs to pyrazine derivatives. Pyrazine derivatives have antitumor, antibiotic, anticonvulsant, antituberculous and diuretic effects as well as kinase, enzymatic and potent tubulin and FtsZ polymerization inhibitory activities. Pyrazine and a variety of alkylpyrazines are flavor and aroma compounds found in baked and roasted goods. Tetramethylpyrazine (also known as ligustrazine) is reported to scavenge superoxide anion and decrease nitric oxide production in human Granulocytes.Recommanded Product: 2-Bromo-5-chloropyrazine